Henry Kuerer (@henrykuerer) 's Twitter Profile
Henry Kuerer

@henrykuerer

MD Anderson Cancer Center

ID: 919231133698494464

calendar_today14-10-2017 15:59:15

322 Tweet

1,1K Takipçi

103 Takip Edilen

Pashtoon Kasi MD, MS (@pashtoonkasi) 's Twitter Profile Photo

#ChalabiPlot💦📊 now in print NEJM. Congratulations 🎉 Myriam Chalabi. 📌nejm.org/doi/full/10.10… With an editorial ✍🏾 by Andrea Cercek. 📌nejm.org/doi/full/10.10… What a good read 📖. Bookmarked.🔖 👏🏾 OncoAlert #CRCSM 💡Neoadjuvant paradigm shift.

#ChalabiPlot💦📊 now in print <a href="/NEJM/">NEJM</a>.

Congratulations 🎉 <a href="/MyriamChalabi/">Myriam Chalabi</a>. 
📌nejm.org/doi/full/10.10…

With an editorial ✍🏾 by <a href="/AndreaCercek/">Andrea Cercek</a>. 
📌nejm.org/doi/full/10.10…

What a good read 📖. Bookmarked.🔖 👏🏾 <a href="/OncoAlert/">OncoAlert</a> #CRCSM

💡Neoadjuvant paradigm shift.
Henry Kuerer (@henrykuerer) 's Twitter Profile Photo

Active Surveillance for Prostate Cancer 10 years after diagnosis, 49% remain free of progression or treatment, <2% developed metastatic disease, <1% died of their disease. Progression/Tx during surveillance were not associated with worse outcomes. jamanetwork.com/journals/jama/…

Active Surveillance for Prostate Cancer 10 years after diagnosis, 49%  remain free of progression or treatment, &lt;2% developed metastatic disease, &lt;1% died of their disease.  Progression/Tx during surveillance were not associated with worse outcomes. jamanetwork.com/journals/jama/…
Henry Kuerer (@henrykuerer) 's Twitter Profile Photo

Breast conserving surgery for patients with a BRCA mutation have higher risk of breast cancer recurrence/development, however most patients did not have another cancer and remained free of mastectomy. jamanetwork.com/journals/jaman…

Breast conserving surgery for patients with a BRCA mutation have higher risk of breast cancer recurrence/development, however most patients did not have another cancer and remained free of mastectomy. jamanetwork.com/journals/jaman…
JAMA Oncology (@jamaonc) 's Twitter Profile Photo

Half of people with inherited BRCA1/2 mutations are men, yet very few men are offered genetic testing or know the importance to their own health. Article reviews data & screening recommendations aimed to help men take action to reduce their risk of cancer. ja.ma/4fcrjSF

Half of people with inherited BRCA1/2 mutations are men, yet very few men are offered genetic testing or know the importance to their own health. Article reviews data &amp; screening recommendations aimed to help men take action to reduce their risk of cancer. ja.ma/4fcrjSF
Henry Kuerer (@henrykuerer) 's Twitter Profile Photo

Feasibility of breast conserving surgery alone in HER2-positive invasive breast cancer exceptional responders to neoadjuvant systemic therapy sciencedirect.com/science/articl…

Feasibility of breast conserving surgery alone in HER2-positive invasive breast cancer exceptional responders to neoadjuvant systemic therapy
sciencedirect.com/science/articl…
Henry Kuerer (@henrykuerer) 's Twitter Profile Photo

Come to NYC Nov 8 to 10 for this multidisciplinary course on controversies/cutting edge treatments for breast cancer. mssm.cloud-cme.com/BC3

Come to NYC Nov 8 to 10 for this multidisciplinary course on controversies/cutting edge treatments for breast cancer. mssm.cloud-cme.com/BC3
CU Surgical Oncology (@cusurgonc) 's Twitter Profile Photo

The Division of Surgical Oncology is thrilled to announce Sarah Tevis, MD, FACS as the new Section Head of Breast Surgery as well as the Co-Director at the Diane O'Connor Thompson Breast Center. Congratulations to Dr.Tevis! Sarah Tevis MD, FACS CU Department of Surgery #ImproveEveryLife

The Division of Surgical Oncology is thrilled to announce Sarah Tevis, MD, FACS as the new Section Head of Breast Surgery as well as the Co-Director at the Diane O'Connor Thompson Breast Center. Congratulations to Dr.Tevis! <a href="/SarahTevisMD/">Sarah Tevis MD, FACS</a> <a href="/CUDeptSurg/">CU Department of Surgery</a> #ImproveEveryLife
OncoAlert (@oncoalert) 's Twitter Profile Photo

THE ICARO Study out on Journal of Clinical Oncology Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i+) This study aimed to evaluate the nodal burden and outcomes in #BreastCancer patients with isolated tumor cells (ITCs) in

THE ICARO Study out on <a href="/JCO_ASCO/">Journal of Clinical Oncology</a>  
Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i+)

This study aimed to evaluate the nodal burden and outcomes in #BreastCancer patients with isolated tumor cells (ITCs) in
JAMA Oncology (@jamaonc) 's Twitter Profile Photo

For select breast cancer patients with complete response to neoadjuvant systemic therapy, radiotherapy alone without breast surgery may be feasible, as no tumor recurrences were observed at 5-year follow-up. ja.ma/426mLaK Henry Kuerer HelenMJohnsonMD Simona F. Shaitelman MD, EdM

For select breast cancer patients with complete response to neoadjuvant systemic therapy, radiotherapy alone without breast surgery may be feasible, as no tumor recurrences were observed at 5-year follow-up. ja.ma/426mLaK <a href="/HenryKuerer/">Henry Kuerer</a> HelenMJohnsonMD <a href="/SFShaitelmanMD/">Simona F. Shaitelman MD, EdM</a>
Henry Kuerer (@henrykuerer) 's Twitter Profile Photo

Join leading experts at RUSH MD Anderson Cancer Center as we discuss advancements in treatments, innovations in surgical techniques and new research shaping the future of breast cancer care.  web.cvent.com/event/338b0794… MD Anderson Cancer Center

Join leading experts at RUSH MD Anderson Cancer Center as we discuss advancements in treatments, innovations in surgical techniques and new research shaping the future of breast cancer care. 

web.cvent.com/event/338b0794…

<a href="/MDAndersonNews/">MD Anderson Cancer Center</a>
Henry Kuerer (@henrykuerer) 's Twitter Profile Photo

Thank you @drclaudia_perez @rushsurgery @rushmedical @rushcancer for an outstanding multidisciplinary #BreastCancer symposium. Energized by the collaboration and commitment to advancing and aligning care! MD Anderson Cancer Center #Oncology #Collaboration #CancerCare

Thank you @drclaudia_perez @rushsurgery @rushmedical @rushcancer for an outstanding multidisciplinary #BreastCancer symposium. Energized by the collaboration and commitment to advancing and aligning care! <a href="/MDAndersonNews/">MD Anderson Cancer Center</a> #Oncology #Collaboration #CancerCare